SEC Comment Letter 0000000000-24-007015 to Microbot Medical Inc. (MBOT)
Microbot Medical Inc.
Date: June 20, 2024 · CIK: 0000883975 · Accession: 0000000000-24-007015
AI Filing Summary & Sentiment
File numbers found in text: 333-280113
Letter
United States securities and exchange commission logo June 20, 2024 Harel Gadot President and Chief Executive Officer Microbot Medical Inc. 288 Grove Street Suite 388 Braintree, MA 02184 Re:Microbot Medical Inc. Registration Statement on Form S-1 Filed June 11, 2024 File No. 333-280113 Dear Harel Gadot: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Robert Augustin at 202-551-8483 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services
Show Raw Text
United States securities and exchange commission logo
June 20, 2024
Harel Gadot
President and Chief Executive Officer
Microbot Medical Inc.
288 Grove Street
Suite 388
Braintree, MA 02184
Re:Microbot Medical Inc.
Registration Statement on Form S-1
Filed June 11, 2024
File No. 333-280113
Dear Harel Gadot:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Robert Augustin at 202-551-8483 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services